Xenon Pharmaceuticals Inc’s recently made public that its PRESIDENT & CEO MORTIMER IAN unloaded Company’s shares for reported $0.9 million on Jan 24 ’25. In the deal valued at $40.20 per share,22,468 shares were sold. As a result of this transaction, MORTIMER IAN now holds 31,302 shares worth roughly $1.23 million.
Then, MORTIMER IAN sold 16,315 shares, generating $660,806 in total proceeds. Upon selling the shares at $40.50, the PRESIDENT & CEO now owns 31,302 shares.
Before that, MORTIMER IAN sold 16,217 shares. Xenon Pharmaceuticals Inc shares valued at $649,977 were divested by the PRESIDENT & CEO at a price of $40.08 per share. As a result of the transaction, MORTIMER IAN now holds 31,302 shares, worth roughly $1.23 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating. Citigroup began covering XENE with “Buy” recommendation on January 04, 2024. Robert W. Baird started covering the stock on December 08, 2023. It rated XENE as “an Outperform”.
Price Performance Review of XENE
On Monday, Xenon Pharmaceuticals Inc [NASDAQ:XENE] saw its stock jump 0.10% to $39.25. Over the last five days, the stock has lost -0.76%. Xenon Pharmaceuticals Inc shares have risen nearly 0.13% since the year began. Nevertheless, the stocks have fallen -16.72% over the past one year. While a 52-week high of $50.99 was reached on 01/02/25, a 52-week low of $35.53 was recorded on 01/13/25. SMA at 50 days reached $40.20, while 200 days put it at $40.35.
Levels Of Support And Resistance For XENE Stock
The 24-hour chart illustrates a support level at 38.76, which if violated will result in even more drops to 38.27. On the upside, there is a resistance level at 39.98. A further resistance level may holdings at 40.71. The Relative Strength Index (RSI) on the 14-day chart is 45.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.55%. Stochastics %K at 37.60% indicates the stock is a holding.
How much short interest is there in Xenon Pharmaceuticals Inc?
A steep rise in short interest was recorded in Xenon Pharmaceuticals Inc stocks on 2024-10-31, dropping by -0.41 million shares to a total of 2.89 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.3 million shares. There was a decline of -14.3%, which implies that there is a negative sentiment for the stock.
